Press "Enter" to skip to content

New patent expiration for Galderma Labs drug CLOBEX

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Galderma Labs drug CLOBEX

Annual Drug Patent Expirations for CLOBEX
Annual Drug Patent Expirations for CLOBEX

Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. It is available from four suppliers. There is one patent protecting this drug and three Paragraph IV challenges.

Drug patent litigation for CLOBEX.

This drug has thirty-one patent family members in twenty-one countries.

The generic ingredient in CLOBEX is clobetasol propionate. Four suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent expiration for Galderma Labs drug CLOBEX
    DrugPatentWatch - Make Better Decisions